(Q28194690)

English

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

scientific article (publication date: 21 January 2003)

Statements

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide (English)
0 references
0 references
Shaun G Goodman
0 references
David Fitchett
0 references
Mary Tan
0 references
Anatoly Langer
0 references
21 January 2003
0 references
0 references
107
0 references
2
0 references
238-44
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit